hello, I'm working with some RNA seq data from a clinical trial. There are about 160 patients (40/group with low, medium, high doses of a drug plus a placebo group). Samples were taken at baseline, week 4, and week 12. I would like to identify genes that are differentially expressed by the drug vs placebo and to explore if there is some sort of dose response in gene expression. Can someone offer some suggestions on how to approach this analysis using DESEQ2? For the drug vs placebo, would a design that includes the factors treatment, week, and patient be applicable and allow me to look at the contrasts of interest(for example, high dose vs placebo or combine doses vs placebo)? I have Ensembl gene identifiers and plan to annotate them with HGNC symbols. Not all Ensembl ids map to a known HGNC symbol. What is the typical way to handle this? Are genes without known symbols be excluded prior to analysis? If not then how would I handle genes that may be identified as differentially expressed but do not map to a known symbol? thanks in advance.